Università degli studi di Perugia
PI: Claudia Monari
Simona Ronchetti
Silvia Bozza
Barbara Camilloni
Expertise, Role and Activity
The Department of Medicine and Surgery at the University of Perugia is a vibrant academic hub with 188 researchers and 16 multidisciplinary research areas. Its focus is centered on biomedical, clinical, and preclinical sciences Furthermore it brings out excellent research in immunology, personalized medicine, rare diseases, and advanced technologies like machine learning and AI. By offering 17 degree programs, 3 PhD programs, 29 postgraduate schools, and 3 master’s programs, it trains skilled professionals to meet the highest standards in healthcare and research.
PI: Claudia Monari
is an Associate Professor in Microbiology and Clinical Microbiology, with expertise in host–pathogen interactions and novel strategies of treatments against bacterial/fungal biofilm infections. In the BactEradiX project, she contributes to evaluate artificial oligonucleotides Z-DNA (WP3) and decorated nanoparticles (WP4) targeting, the bactericidal activity of anti-gene artificial oligonucleotides (WP5) and the activity of BactEradix prototypes (WP6). Claudia is the executive of UNIPG Unit and WP2 leader for “Characterization of Z-DNA in biofilms from priority pathogens”.
Simona Ronchetti
is an Associate Professor in Pharmacology, with expertise in inflammation and inflammatory diseases and with particular skills in molecular biology and imaging techniques. Simona contributes to biofilm characterization (WP2), artificial oligonucleotides Z-DNA targeting (WP3), and evaluate the efficacy of BactEradix prototypes (WP6).
Silvia Bozza
is an Associate Professor in Microbiology and Clinical Microbiology, with expertise in host-microbiota-pathogen interactions and opportunistic infections in immunocompromised patients. Silvia focuses on biofilm characterization (WP2), evaluating the bactericidal activity of anti-gene artificial oligonucleotides (WP5), and in assessing the efficacy of BactEradix prototypes (WP6).
Barbara Camilloni
is a Researcher in Microbiology and Clinical Microbiology, specialized in host-parasite interaction with particular interests in emerging microorganisms causing nosocomial and community epidemics and in their genetic and phenotypic characterization. Barbara is involved in assessing the artificial oligonucleotides Z-DNA targeting (WP3) nanoparticle-biofilm interaction (WP4) and in assessing the efficacy of BactEradix prototypes (WP6).
All the Consortium
